Association of PPP2CA polymorphisms with SLE susceptibility in multiple ethnic groups

Objective—T cells from patients with SLE express increased amounts of PP2Ac which contribute to decreased production of IL-2. Because IL-2 is important in the regulation of several aspects of the immune response, it has been proposed that PP2Ac contributes to the expression of SLE. This study was designed to determine whether genetic variants of PPP2AC are linked to the expression of SLE and specific clinical manifestations and account for the increased expression of PP2Ac. Methods—We conducted a trans-ethnic study consisting of 8,695 SLE cases and 7,308 controls from four different ancestries. Eighteen single-nucleotide polymorphisms (SNPs) across the PPP2CA were genotyped using an Illumina custom array. PPP2CA expression in SLE and control T cells was analyzed by real-time PCR. Results—A 32-kb haplotype comprised of multiple SNPs of PPP2CA showed significant association with SLE in Hispanic Americans (HA), European Americans (EA) and Asians but not in African-Americans (AA). Conditional analyses revealed that SNP rs7704116 in intron 1 showed consistently strong association with SLE across Asian, EA and HA populations (pmeta=3.8×10, OR=1.3[1.14–1.31]). In EA, the largest ethnic dataset, the risk A allele of rs7704116 was associated with the presence of renal disease, anti-dsDNA and anti-RNP antibodies. PPP2CA expression was approximately 2-fold higher in SLE patients carrying the rs7704116 AG genotype than those carrying GG genotype (p = 0.008). Conclusion—Our data provide the first evidence for an association between PPP2CA polymorphisms and elevated PP2Ac transcript levels in T cells, which implicates a new molecular pathway for SLE susceptibility in EA, HA and Asians.

[1]  L. Morel,et al.  Murine Models of Systemic Lupus Erythematosus , 2011, Journal of biomedicine & biotechnology.

[2]  P. Gregersen,et al.  Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. , 2011, American journal of human genetics.

[3]  A. Abbas,et al.  Cutting Edge: Mechanisms of IL-2–Dependent Maintenance of Functional Regulatory T Cells , 2010, The Journal of Immunology.

[4]  B. Tsao,et al.  Genetic susceptibility to systemic lupus erythematosus in the genomic era , 2010, Nature Reviews Rheumatology.

[5]  L. Ashman,et al.  Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers. , 2010, Cancer research.

[6]  G. Tsokos,et al.  T cells as therapeutic targets in SLE , 2010, Nature Reviews Rheumatology.

[7]  G. Tsokos,et al.  Pathogenesis of human systemic lupus erythematosus: recent advances. , 2010, Trends in molecular medicine.

[8]  P. Sham,et al.  Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus , 2010, PLoS genetics.

[9]  C. Hoggart,et al.  Pathway Analysis of GWAS Provides New Insights into Genetic Susceptibility to 3 Inflammatory Diseases , 2009, PloS one.

[10]  Gerald McGwin,et al.  A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus , 2009, Nature Genetics.

[11]  Ying Wang,et al.  Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus , 2009, Nature Genetics.

[12]  Yigong Shi Serine/Threonine Phosphatases: Mechanism through Structure , 2009, Cell.

[13]  G. Tsokos,et al.  Methylation Status of CpG Islands Flanking a cAMP Response Element Motif on the Protein Phosphatase 2Acα Promoter Determines CREB Binding and Activity1 , 2009, The Journal of Immunology.

[14]  R. Bernards,et al.  Protein phosphatase 2A regulatory subunits and cancer. , 2009, Biochimica et biophysica acta.

[15]  A. Abbas,et al.  Interleukin‐2 in the development and control of inflammatory disease , 2008, Immunological reviews.

[16]  David Altshuler,et al.  Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus , 2008, Nature Genetics.

[17]  Mark Shriver,et al.  A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: utility and applications , 2008, Human mutation.

[18]  V. Janssens,et al.  PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). , 2008, Trends in biochemical sciences.

[19]  Geoffrey Hom,et al.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. , 2008, The New England journal of medicine.

[20]  Leonid Kruglyak,et al.  The road to genome-wide association studies , 2008, Nature Reviews Genetics.

[21]  D. Gladman,et al.  Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. , 2008, Arthritis and rheumatism.

[22]  Marta E Alarcón-Riquelme,et al.  Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci , 2008, Nature Genetics.

[23]  Sandra D'Alfonso,et al.  Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus , 2008, Nature Genetics.

[24]  L. Czirják,et al.  Association between early onset and organ manifestations of systemic lupus erythematosus (SLE) and a down-regulating promoter polymorphism in the MBL2 gene. , 2007, Clinical immunology.

[25]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[26]  Pak Chung Sham,et al.  WHAP: haplotype-based association analysis , 2007, Bioinform..

[27]  A. Giordano,et al.  Interaction of PP2A catalytic subunit with Rb2/p130 is required for all‐trans retinoic acid suppression of ovarian carcinoma cell growth , 2006, Journal of cellular physiology.

[28]  G. Tsokos,et al.  Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. , 2005, The Journal of clinical investigation.

[29]  J. Hirschhorn,et al.  A comprehensive review of genetic association studies , 2002, Genetics in Medicine.

[30]  V. Janssens,et al.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. , 2001, The Biochemical journal.

[31]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[32]  S. Gendler,et al.  Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). , 1983, Journal of immunology.